Loading…
Transcat, Inc. provides calibration and laboratory instrument services in the United States, Canada, and internationally. It operates through two segments, Service and Distribution. The Service segment offers calibration, repair, inspection, analytical qualification, preventative maintenance, consulting, and other related services. This segment also provides CalTrak, a proprietary document and asset management system that is used to manage the workflow of its calibration service centers and customers' assets; and Compliance, Control, and Cost, an online customer portal that provides its customers with web-based asset management capability, as well as a safe and secure off-site archive of calibration and other service records. The Distribution segment sells and rents test, measurement, and control instruments for customers' test and measurement instrumentation needs, as well as value-added services, such as calibration/certification of equipment purchase, equipment rental, used equipment for sale, and equipment kitting. This segment markets and sells its products through website, digital and print advertising, proactive outbound sales, and an inbound call center. The company provides services and products to highly regulated industries, principally life science, which includes companies in the pharmaceutical, biotechnology, medical device, and other FDA-regulated industries; and additional industries, including aerospace and defense, industrial manufacturing, energy and utilities, chemical manufacturing, and other industries that require accuracy in processes and confirmation of the capabilities of their equipment. Transcat, Inc. was incorporated in 1964 and is headquartered in Rochester, New York.
5-year financial trends. Figures in USD millions.
Latest fiscal year: 2025
Year-by-year revenue, profitability, and cash flow (USD millions, last 10 years)
| Year | Revenue | EBITDA | Net Profit | FCF | ROE | Rev Growth 1Y | NP Growth 1Y |
|---|---|---|---|---|---|---|---|
| 2025 | $278M | $38M | $15M | $26M | 5.1% | 7.3% | 6.4% |
| 2024 | $259M | $34M | $14M | $19M | 6.1% | 12.5% | 27.7% |
| 2023 | $231M | $27M | $11M | $8M | 10.7% | 12.5% | -6.1% |
| 2022 | $205M | $24M | $11M | $7M | 13.2% | - | - |
Income statement, balance sheet, and cash flow as reported
Consolidated Figures in USD Millions.
| Metric | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|
| Total Revenue | 204.96 | 230.57 | 259.48 | 278.42 |
| Cost Of Revenue | 146.52 | 162.21 | 175.68 | 188.97 |
| Gross Profit | 58.44 | 68.36 | 83.81 | 89.45 |
| Operating Expense | 44.30 | 52.11 | 64.03 | 71.58 |
| Operating Income | 14.14 | 16.25 | 19.78 | 17.87 |
| EBITDA | 23.57 | 26.86 | 33.82 | 37.69 |
| EBIT | 14 | 15.90 | 20.27 | 19.12 |
| Pretax Income | 13.19 | 13.49 | 18.44 | 18.33 |
| Tax Provision | 1.81 | 2.80 | 4.79 | 3.81 |
| Net Income | 11.38 | 10.69 | 13.65 | 14.52 |
| Net Income Common Stockholders | 11.38 | 10.69 | 13.65 | 14.52 |
| Total Expenses | 190.82 | 214.32 | 239.70 | 260.55 |
| Interest Expense | 0.81 | 2.42 | 1.83 | 0.80 |
| Interest Income | 0 | 0 | 0.81 | 0.82 |
| Selling General And Administration | 44.30 | 52.11 | 64.03 | 71.58 |
| Normalized EBITDA | 23.57 | 26.86 | 33.82 | 37.69 |
| Normalized Income | 11.38 | 10.69 | 13.65 | 14.52 |
| Basic EPS | 1.52 | 1.42 | 1.66 | 1.58 |
| Diluted EPS | 1.50 | 1.40 | 1.63 | 1.57 |
| Tax Effect Of Unusual Items | 0 | 0 | 0 | 0 |
| Tax Rate For Calcs | 0.14 | 0.21 | 0.26 | 0.21 |
| Net Income From Continuing Operation Net Minority Interest | 11.38 | 10.69 | 13.65 | 14.52 |
| Reconciled Depreciation | 9.57 | 10.96 | 13.54 | 18.57 |
| Reconciled Cost Of Revenue | 146.52 | 162.21 | 175.68 | 188.97 |
| Net Interest Income | -0.81 | -2.42 | -1.03 | 0.03 |
| Net Income From Continuing And Discontinued Operation | 11.38 | 10.69 | 13.65 | 14.52 |
| Total Operating Income As Reported | 14.14 | 16.25 | 19.78 | 17.87 |
| Diluted Average Shares | 7.59 | 7.64 | 8.35 | 9.25 |
| Basic Average Shares | 7.50 | 7.55 | 8.24 | 9.19 |
| Diluted NI Availto Com Stockholders | 11.38 | 10.69 | 13.65 | 14.52 |
| Net Income Including Noncontrolling Interests | 11.38 | 10.69 | 13.65 | 14.52 |
| Net Income Continuous Operations | 11.38 | 10.69 | 13.65 | 14.52 |
| Other Income Expense | -0.14 | -0.34 | -0.32 | 0.42 |
| Other Non Operating Income Expenses | -0.14 | -0.34 | -0.32 | 0.42 |
| Net Non Operating Interest Income Expense | -0.81 | -2.42 | -1.03 | 0.03 |
| Interest Expense Non Operating | 0.81 | 2.42 | 1.83 | 0.80 |
| Interest Income Non Operating | 0 | 0 | 0.81 | 0.82 |
| Selling And Marketing Expense | 20.65 | 24.76 | 28.71 | 33.34 |
| General And Administrative Expense | 23.65 | 27.35 | 35.31 | 38.24 |
| Other Gand A | 23.65 | 27.35 | 35.31 | 38.24 |
| Operating Revenue | 204.96 | 230.57 | 259.48 | 278.42 |
Industrials sector peers, ranked by market cap
| Company | Ticker | Market Cap | P/E | P/B | ROE | EV/EBITDA |
|---|---|---|---|---|---|---|
| Transcat, Inc.this co. | TRNS | $695M | 87.59↑ premium | 2.34 | 5.1% | 19.97 |
| Janus International Group, Inc. | JBI | $711M | 13.71 | 1.26 | 9.4% | 7.12 |
| Cardinal Infrastructure Group Inc. | CDNL | $701M | 30.18 | 11.73 | 16.3% | 10.97 |
| Hyster-Yale, Inc. | HY | $686M | - | 1.44 | -12.2% | 20.87 |
| Smith & Wesson Brands, Inc. | SWBI | $686M |
| 64.21 |
| 1.89 |
| 3.6% |
| 14.41 |
| Sturm, Ruger & Company, Inc. | RGR | $684M | - | 2.41 | -1.5% | 51.26 |
| Latham Group, Inc. | SWIM | $683M | 64.89 | 1.68 | 2.7% | 11.15 |
| Serve Robotics Inc. | SERV | $680M | - | 1.92 | -28.9% | -4.28 |
| Safe Bulkers, Inc. | SB | $675M | 22.00 | 0.81 | 4.6% | 8.44 |
| Peer Median | - | 30.18 | 1.78 | 3.2% | 11.06 | |